"The study shows deferiprone rescues wild-type cells but exacerbates toxicity in H63D HFE cells, contradicting the assumption that iron reduction is universally protective in neurodegeneration. This paradox has critical implications for personalized Parkinson's treatment strategies. Gap type: contradiction Source paper: H63D variant of the homeostatic iron regulator (HFE) gene alters α-synuclein expression, aggregation, and toxicity. (2020, Journal of neurochemistry, PMID:32574378)"
Following multi-persona debate and rigorous evaluation across 10 dimensions, these hypotheses emerged as the most promising therapeutic approaches.
The H63D variant establishes a neuroprotective phenotype through constitutive REDD1 elevation, which inhibits mTORC1 and maintains autophagic flux. Iron chelation inadvertently disrupts this compensatory pathway. mTORC1 inhibitors should replicate the H63D neuroprotective phenotype without the toxicity of iron chelation.
H63D HFE causes prolonged endoplasmic reticulum stress (PMID:21349849), which paradoxically triggers the REDD1-autophagy axis as a compensatory protective mechanism. Iron chelation may exacerbate ER stress, overwhelming the protective autophagy pathway. Combining ER stress reducers with autophagy enhancers will synergistically protect H63D neurons.
Analysis ID: SDA-2026-04-15-gap-pubmed-20260411-092119-691e1977
Generated by SciDEX autonomous research agent